Total Assets for Biogen (BIIB)
According to Biogen's latest reported financial statements, the company's latest reported total assets is $29.44B USD. Total assets sum everything the company reports owning at the end of each reporting period — cash, receivables, inventory, property, plant, equipment, intangibles, and other holdings — as filed on the balance sheet. Compare with total liabilities and net assets for the capital-structure picture.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
BIIB
Currently viewingTotal AssetsSwitch metric
Latest period
$29.44B
YoY change
+5.0%
5Y CAGR
+3.6%
Peak year (2025)
$29.44B
Latest annual
$29.44B
Total Assets history chart for Biogen (BIIB) from 1985 to 2025
Total Assets history table for Biogen (BIIB) from 1985 to 2025
| Fiscal year | Period ended | Reported | Total Assets | YoY |
|---|---|---|---|---|
| 2025 | $29.44B | +5.0% | ||
| 2024 | $28.05B | +4.5% | ||
| 2023 | $26.84B | +9.3% | ||
| 2022 | $24.55B | +2.8% | ||
| 2021 | $23.88B | -3.0% | ||
| 2020 | $24.62B | -9.6% | ||
| 2019 | $27.23B | +7.7% | ||
| 2018 | $25.29B | +6.9% | ||
| 2017 | $23.65B | +3.4% | ||
| 2016 | $22.88B | +17.3% | ||
| 2015 | $19.50B | +36.2% | ||
| 2014 | $14.32B | +20.7% | ||
| 2013 | $11.86B | +17.1% | ||
| 2012 | $10.13B | +11.9% | ||
| 2011 | $9.05B | +11.8% | ||
| 2010 | $8.09B | -5.4% | ||
| 2009 | $8.55B | +0.9% | ||
| 2008 | $8.48B | -1.7% | ||
| 2007 | $8.63B | +0.9% | ||
| 2006 | $8.55B | +2.2% | ||
| 2005 | $8.37B | -8.7% | ||
| 2004 | $9.17B | -3.6% | ||
| 2003 | $9.50B | +373.5% | ||
| 2002 | $2.01B | +16.6% | ||
| 2001 | $1.72B | +20.2% | ||
| 2000 | $1.43B | +12.0% | ||
| 1999 | $1.28B | +38.2% | ||
| 1998 | $924.72M | +13.6% | ||
| 1997 | $813.83M | +28.2% | ||
| 1996 | $634.57M | +35.2% | ||
| 1995 | $469.20M | +24.2% | ||
| 1994 | $377.86M | +5.8% | ||
| 1993 | $357.00M | +14.7% | ||
| 1992 | $311.20M | +23.0% | ||
| 1991 | $253.10M | +59.7% | ||
| 1990 | $158.50M | +9.2% | ||
| 1989 | $145.20M | +79.5% | ||
| 1988 | $80.90M | +0.2% | ||
| 1987 | $80.70M | -20.0% | ||
| 1986 | $100.90M | +17.6% | ||
| 1985 | $85.80M | — |
Total Assets values are taken from Biogen's reported balance sheets (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
In 2025, Biogen (BIIB) total assets totalled $29.44B – edged up 5.0% year-over-year.
Over 2020–2025 (5 years), Biogen total assets expanded at a +3.6% compound annual rate, sustaining 4 straight years of year-over-year growth.
2025 marks the peak total assets at $29.44B, with the historical low of $80.70M recorded in 1987.
Within Healthcare, Biogen (BIIB) ranks 9th among 8 peers we track. The peer median for total assets is $135.41B.
Biogen Total Assets by Year
Biogen Total Assets 2025: $29.44B
Biogen total assets in 2025 was $29.44B, edged up 5.0% from 2024. This figure represents the highest annual value in the available history.
Biogen Total Assets 2024: $28.05B
Biogen total assets in 2024 was $28.05B, edged up 4.5% from 2023.
Biogen Total Assets 2023: $26.84B
Biogen total assets in 2023 was $26.84B, grew 9.3% from 2022.
Biogen Total Assets 2022: $24.55B
Biogen total assets in 2022 was $24.55B, edged up 2.8% from 2021.
Biogen Total Assets 2021: $23.88B
Biogen total assets in 2021 was $23.88B.
See more financial history for Biogen (BIIB).
Sector peers — Total Assets
Companies in the same sector as Biogen, ranked by their latest total assets.
| Company | Total Assets | Sector |
|---|---|---|
| Novo Nordisk A/S (NVO) | $542.90B | Healthcare |
| UnitedHealth Group Incorporated (UNH) | $309.58B | Healthcare |
| Johnson & Johnson (JNJ) | $199.21B | Healthcare |
| Merck & Co., Inc. (MRK) | $136.87B | Healthcare |
| AbbVie Inc. (ABBV) | $133.96B | Healthcare |
| AstraZeneca PLC (AZN) | $114.07B | Healthcare |
| Eli Lilly and Company (LLY) | $112.48B | Healthcare |
| Amgen Inc. (AMGN) | $90.59B | Healthcare |
Frequently asked questions
What is Biogen's total assets?
- Latest reported total assets for Biogen (BIIB) is $29.44B (period ending December 31, 2025).
How has Biogen total assets changed year-over-year?
- Biogen (BIIB) total assets changed +5.0% year-over-year on the latest annual filing.
What is the long-term growth rate of Biogen total assets?
- Biogen (BIIB) total assets compound annual growth rate is +3.6% over the most recent 5 years available.
When did Biogen total assets hit its highest annual value?
- Biogen total assets reached its highest annual value of $29.44B in 2025.
What was Biogen total assets in 2024?
- Biogen (BIIB) total assets in 2024 was $28.05B.
What was Biogen total assets in 2025?
- Biogen (BIIB) total assets in 2025 was $29.44B.
Metrics overview
Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.
Explore more
BIIB Overview
Company profile, financial tools, and key metrics
BIIB Revenue Counter
Earns $311.09 every second. See per minute, hour, and day.
BIIB Earnings Counter
Earns $41.01 per second net profit. See per minute, hour, and day.
BIIB Economic Scale
Exceeds Bermuda's GDP. Compare with world economies.
BIIB What If Invested
What if you had invested $1,000? See historical returns from any date.
BIIB How It Makes Money
Discover visual breakdown of $9.81B in revenue — where it comes from and where it goes.
BIIB Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
BIIB Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
BIIB Daily Price Character
Explosive · 48.1% historical win rate (green days). Streaks & record days.
BIIB Buybacks
Recent repurchase activity. Shareholder yield & SBC comparison.
BIIB Stock Split History
2 splits on record. Dates, ratios, and cumulative multiple.